Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy

被引:294
作者
Nair, Dileep R. [1 ]
Laxer, Kenneth D. [2 ]
Weber, Peter B. [2 ]
Murro, Anthony M. [3 ]
Park, Yong D. [3 ]
Barkley, Gregory L. [4 ]
Smith, Brien J. [5 ]
Gwinn, Ryder P. [6 ]
Doherty, Michael J. [6 ]
Noe, Katherine H. [7 ]
Zimmerman, Richard S. [7 ]
Bergey, Gregory K. [8 ]
Anderson, William S. [8 ]
Heck, Christianne [9 ]
Liu, Charles Y. [9 ]
Lee, Ricky W. [10 ]
Sadler, Toni [10 ]
Duckrow, Robert B. [11 ]
Hirsch, Lawrence J. [11 ]
Wharen, Robert E., Jr. [12 ]
Tatum, William [12 ]
Srinivasan, Shraddha [13 ]
McKhann, Guy M. [13 ]
Agostini, Mark A. [14 ]
Alexopoulos, Andreas V. [1 ]
Jobst, Barbara C. [15 ]
Roberts, David W. [15 ]
Salanova, Vicenta [16 ]
Witt, Thomas C. [16 ]
Cash, Sydney S. [17 ]
Cole, Andrew J. [17 ]
Worrell, Gregory A. [18 ]
Lundstrom, Brian N. [18 ]
Edwards, Jonathan C. [19 ]
Halford, Jonathan J. [19 ]
Spencer, David C. [20 ]
Ernst, Lia [20 ]
Skidmore, Christopher T. [21 ]
Sperling, Michael R. [21 ]
Miller, Ian [22 ]
Geller, Eric B. [23 ]
Berg, Michel J. [24 ]
Fessler, A. James [24 ]
Rutecki, Paul [25 ]
Goldman, Alica M. [26 ]
Mizrahi, Eli M. [26 ]
Gross, Robert E. [27 ]
Shields, Donald C. [28 ]
Schwartz, Theodore H. [29 ]
Labar, Douglas R. [29 ]
机构
[1] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA
[2] Calif Pacific Med Ctr, San Francisco, CA USA
[3] Augusta Univ, Augusta, GA USA
[4] Henry Ford Hosp, Detroit, MI 48202 USA
[5] Ohio Hlth Neurosci, Columbus, OH USA
[6] Swedish Neurosci Inst, Seattle, WA USA
[7] Mayo Clin Arizona, Scottsdale, AZ USA
[8] Johns Hopkins Med, Baltimore, MD USA
[9] USC, Keck Sch Med, Los Angeles, CA USA
[10] Via Christi Epilepsy Ctr, Wichita, KS USA
[11] Yale Univ, Sch Med, New Haven, CT USA
[12] Mayo Clin Florida, Jacksonville, FL USA
[13] Columbia Univ, Med Ctr, New York, NY USA
[14] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[15] Geisel Sch Med Dartmouth, Hanover, NH USA
[16] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[17] Massachusetts Gen Hosp, Boston, MA 02114 USA
[18] Mayo Clin Minnesota, Rochester, MN USA
[19] Med Univ South Carolina, Charleston, SC 29425 USA
[20] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[21] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[22] Nicklaus Childrens Hosp, Miami, FL USA
[23] St Barnabas Hosp, Livingston, NJ USA
[24] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[25] Univ Wisconsin Hosp & Clin, Madison, WI 53792 USA
[26] Baylor Coll Med, Houston, TX 77030 USA
[27] Emory Univ, Sch Med, Atlanta, GA USA
[28] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA
[29] Weill Cornell Med Coll, New York, NY USA
[30] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA
[31] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA
[32] Univ Florida, Gainesville, FL USA
[33] Wake Forest Univ Hlth Sci, Winston Salem, NC USA
[34] NeuroPace Inc, Mountain View, CA 94043 USA
[35] Stanford Univ, Palo Alto, CA 94304 USA
关键词
SUDDEN UNEXPECTED DEATH; QUALITY-OF-LIFE; LOCALIZED NEOCORTICAL RESECTIONS; VAGUS NERVE-STIMULATION; TEMPORAL-LOBE; LONG-TERM; STANDARDS-SUBCOMMITTEE; CORTICAL STIMULATION; PRACTICE PARAMETER; SURGERY;
D O I
10.1212/WNL.0000000000010154
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective To prospectively evaluate safety and efficacy of brain-responsive neurostimulation in adults with medically intractable focal onset seizures (FOS) over 9 years. Methods Adults treated with brain-responsive neurostimulation in 2-year feasibility or randomized controlled trials were enrolled in a long-term prospective open label trial (LTT) to assess safety, efficacy, and quality of life (QOL) over an additional 7 years. Safety was assessed as adverse events (AEs), efficacy as median percent change in seizure frequency and responder rate, and QOL with the Quality of Life in Epilepsy (QOLIE-89) inventory. Results Of 256 patients treated in the initial trials, 230 participated in the LTT. At 9 years, the median percent reduction in seizure frequency was 75% (p < 0.0001, Wilcoxon signed rank), responder rate was 73%, and 35% had a >= 90% reduction in seizure frequency. We found that 18.4% (47 of 256) experienced >= 1 year of seizure freedom, with 62% (29 of 47) seizure-free at the last follow-up and an average seizure-free period of 3.2 years (range 1.04-9.6 years). Overall QOL and epilepsy-targeted and cognitive domains of QOLIE-89 remained significantly improved (p < 0.05). There were no serious AEs related to stimulation, and the sudden unexplained death in epilepsy (SUDEP) rate was significantly lower than predefined comparators (p < 0.05, 1-tailed chi(2)). Conclusions Adjunctive brain-responsive neurostimulation provides significant and sustained reductions in the frequency of FOS with improved QOL. Stimulation was well tolerated; implantation-related AEs were typical of other neurostimulation devices; and SUDEP rates were low. ClinicalTrials.gov identifier NCT00572195. Classification of evidence This study provides Class IV evidence that brain-responsive neurostimulation significantly reduces focal seizures with acceptable safety over 9 years.
引用
收藏
页码:E1244 / E1256
页数:13
相关论文
共 45 条
  • [1] [Anonymous], 2018, RNS SYSTEM USER MANU
  • [2] Gauging seizure risk
    Baud, Maxime O.
    Rao, Vikram R.
    [J]. NEUROLOGY, 2018, 91 (21) : 967 - 973
  • [3] Multi-day rhythms modulate seizure risk in epilepsy
    Baud, Maxime O.
    Kleen, Jonathan K.
    Mirro, Emily A.
    Andrechak, Jason C.
    King-Stephens, David
    Chang, Edward F.
    Rao, Vikram R.
    [J]. NATURE COMMUNICATIONS, 2018, 9
  • [4] Surgical and neurological complications in a series of 708 epilepsy surgery procedures
    Behrens, E
    Schramm, J
    Zentner, J
    Konig, R
    [J]. NEUROSURGERY, 1997, 41 (01) : 1 - 9
  • [5] Long-term treatment with responsive brain stimulation in adults with refractory partial seizures
    Bergey, Gregory K.
    Morrell, Martha J.
    Mizrahi, Eli M.
    Goldman, Alica
    King-Stephens, David
    Nair, Dileep
    Srinivasan, Shraddha
    Jobst, Barbara
    Gross, Robert E.
    Shields, Donald C.
    Barkley, Gregory
    Salanova, Vicenta
    Olejniczak, Piotr
    Cole, Andrew
    Cash, Sydney S.
    Noe, Katherine
    Wharen, Robert
    Worrell, Gregory
    Murro, Anthony M.
    Edwards, Jonathan
    Duchowny, Michael
    Spencer, David
    Smith, Michael
    Geller, Eric
    Gwinn, Ryder
    Skidmore, Christopher
    Eisenschenk, Stephan
    Berg, Michel
    Heck, Christianne
    Van Ness, Paul
    Fountain, Nathan
    Rutecki, Paul
    Massey, Andrew
    O'Donovan, Cormac
    Labar, Douglas
    Duckrow, Robert B.
    Hirsch, Lawrence J.
    Courtney, Tracy
    Sun, Felice T.
    Seale, Cairn G.
    [J]. NEUROLOGY, 2015, 84 (08) : 810 - 817
  • [6] SUDDEN UNEXPECTED DEATH IN EPILEPSY - A SERIES FROM AN EPILEPSY SURGERY PROGRAM AND SPECULATION ON THE RELATIONSHIP TO SUDDEN CARDIAC DEATH
    DASHEIFF, RM
    [J]. JOURNAL OF CLINICAL NEUROPHYSIOLOGY, 1991, 8 (02) : 216 - 222
  • [7] Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures
    DeGiorgio, CM
    Schachter, SC
    Handforth, A
    Salinsky, M
    Thompson, J
    Uthman, B
    Reed, R
    Collins, S
    Tecoma, E
    Morris, GL
    Vaughn, B
    Naritoku, DK
    Henry, T
    Labar, D
    Gilmartin, R
    Labiner, D
    Osorio, I
    Ristanovic, R
    Jones, J
    Murphy, J
    Ney, G
    Wheless, J
    Lewis, P
    Heck, C
    [J]. EPILEPSIA, 2000, 41 (09) : 1195 - 1200
  • [8] Quantitative electrocorticographic biomarkers of clinical outcomes in mesial temporal lobe epileptic patients treated with the RNS® system
    Desai, Sharanya Arcot
    Tcheng, Thomas K.
    Morrell, Martha J.
    [J]. CLINICAL NEUROPHYSIOLOGY, 2019, 130 (08) : 1364 - 1374
  • [9] DEVELOPMENT OF THE QUALITY-OF-LIFE IN EPILEPSY INVENTORY
    DEVINSKY, O
    VICKREY, BG
    CRAMER, J
    PERRINE, K
    HERMANN, B
    MEADOR, K
    HAYS, RD
    [J]. EPILEPSIA, 1995, 36 (11) : 1089 - 1104
  • [10] Sudden unexpected death in epilepsy in patients treated with brain-responsive neurostimulation
    Devinsky, Orrin
    Friedman, Daniel
    Duckrow, Robert B.
    Fountain, Nathan B.
    Gwinn, Ryder P.
    Leiphart, James W.
    Murro, Anthony M.
    Van Ness, Paul C.
    [J]. EPILEPSIA, 2018, 59 (03) : 555 - 561